M
Moleculin Biotech, Inc. (MBRX)
NCM – Real Time Price. Currency in USD
2.44
+0.01 (0.41%)
At close: Mar 27, 2026, 4:00 PM EDT
2.20
-0.24 (-9.84%)
After-hours: Mar 27, 2026, 7:55 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.44
+0.01 (0.41%)
At close: Mar 27, 2026, 4:00 PM EDT
2.20
-0.24 (-9.84%)
After-hours: Mar 27, 2026, 7:55 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.41 | 6.05 | 7.0 | |
| Quick ratio | 1.41 | 5.63 | 7.0 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -222K | -127K | -126K | -90K | -90K |
| Operating Income | -31M | -30M | -27M | -25M | -25M |
| Net Income | -29M | -30M | -26M | -34M | -24M |
| EBITDA | -30M | -30M | -27M | -25M | -25M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 89.97 | 5.5 |
| Next quarter | N/A | 87.84 | 5.5 |
| Current year | N/A | 75.69 | 5.5 |
| Next year | N/A | 42.62 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 161.23 | 115.48 | 25.71 | 10 |
| Y/Y | 999 | 336.21 | -57.83 | -5.56 | 5.5 |
| 3y average | 999 | -6.28 | 46.87 | 6.26 | 6.5 |
| 5y average | 999 | -18.6 | 34.52 | -6.35 | 5.5 |
| Weighted average score | 6.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $8.9M significantly exceed its total debt $359.0K, ensuring strong financial flexibility
Total current assets $9.7M exceed Total current liabilities $6.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$5.4M limits the company's ability to reinvest or pay down debt